recombinant antibody-based AIMs (APO-T)

N/A

Report date: 2025/06/11 20:01:15

Base Information

Drug Namerecombinant antibody-based AIMs (APO-T)
Drug Alias Namerecombinant antibody-based apoptosis inducing molecules (APO-T)AIM (Apo-T)AIM-1AIM-2
ClassificationBiologics > Protein drugs > Immunoglobulin > AntibodyBiologics > Protein drugs > Recombinant protein
Mechanisms of ActionApoptosis stimulants
TargetsUpdating
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryNetherlands
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesAPO-T
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAPO-T
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A